Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.
BICTF stock price ended at $0.01 on Wednesday, after rising Infinity%
On the latest trading day May 14, 2025, the stock price of BICTF rose by Infinity%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 38.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 39.0K shares were traded, equating to a market value of approximately $202.0K.
BICTF Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
BICTF currently exhibits 0 buy signals and 0 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of Infinity% during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for BICTF
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for BICTF. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to BICTF?
What are the Fibonacci retracement levels for BICTF?
What is the RSI for Biocure Technology Inc.?
What is Biocure Technology Inc. price for the next 12 months?
How high is Biocure Technology Inc. expected to go?